Related Experiment Video
Updated: Jul 24, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Aspergillus peritonitis: therapy, survival, and return to peritoneal dialysis
Abstract:
Peritonitis caused by fungi of the species Aspergillus is rare in peritoneal dialysis patients and is associated with high mortality. Four of the six reported survivors have been unable to resume peritoneal dialysis. We report the successful treatment of Aspergillus niger peritonitis with a combination of intravenous amphotericin B and peritoneal catheter removal in a patient on continuous ambulatory peritoneal dialysis (CAPD), and review previously reported cases of Aspergillus peritonitis. Our patient returned to CAPD after 2 months and has maintained good peritoneal transport 1 year after resumption of CAPD. The early recognition and aggressive treatment of peritonitis due to Aspergillus sp may allow eventual return to and successful maintenance of CAPD.
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Acute Pyelonephritis II: Diagnostic Studies and Management
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Acute Kidney Injury V: Interprofessional Care

